Tc-99m HMPAO labeled WBC

Last revised by Andrew Murphy on 3 Apr 2020

Tc-99m HMPAO (hexamethylpropyleneamine oxime) labeled WBC is one of the technetium radiopharmaceuticals used in WBC imaging.

There are three potential radiochemical impurities in the 99mTc-HMPAO: a hydrophilic secondary complex, the free pertechnetate and the reduced 99mTc-hydrolyzate. 1The minimum expected radiochemical purity is approximately 80%.

Characteristics

  • photon energy: 140 KeV
  • physical half life: 6 hours
  • biological half life: 4 hours
  • molecular geometry: square pyramidal
  • normal distribution: spleen, liver, kidney, bone marrow
  • pharmacokinetics: radiolabel in vitro
  • excretion: hepatobiliary, renal
  • target organ: colon, bladder, spleen
  • miscellaneous facts:
    • lipophilic: crosses cell membranes and the blood brain barrier; bound to mitochondria and the nucleus within cells
    • better image quality and lower radiation dose than In-111 WBC
    • high false positive rate for spine infection (Ga-67 may be preferable)

Uses, doses and timings

  • infection
    • adult dose: 370 MBq (10 mCi) IV
    • timing: 2 hours for abdominal
    • timing: 4 hours for skeletal (30 min whole body acquisition, 10 min spots)

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.